PSOGI World News - October 2025 Newsletter

A quarterly newsletter with the latest news, views and announcements from Peritoneal Surface Oncology Group International (PSOGI)

Led by pioneering surgical oncologist Dr. Paul Sugarbaker, PSOGI is a collaboration of experts from around the world on the treatment of peritoneal cancer and is dedicated to improving treatment and survival of patients with peritoneal metastases. While PSOGI World News is a quarterly publication primarily intended for healthcare professionals, this issue offers valuable insights for patients and caregivers navigating these complex cancers.

We are proud to share their quarterly newsletter.

---

The latest issue of PSOGI World News highlights continued global collaboration and promising advances across peritoneal surface oncology. Here are the key updates from the Autumn 2025 edition:

Research & Scientific Advances

This issue features exciting progress in biomarker discovery for earlier cancer detection and more precise treatment targeting. Several ongoing trials are showing encouraging early results—particularly those exploring immunotherapy combined with targeted therapies.

PSOGI also emphasized the growing importance of genomic and molecular profiling in clinical care, paving the way for more personalized treatment plans and smarter trial enrollment.

Clinical & Practice Insights

Updated consensus guidelines on cytoreductive surgery and HIPEC aim to clarify patient selection, safety metrics, and best practices worldwide. The newsletter also shared unique case reports highlighting complex surgical approaches and lessons learned from international centers.

A strong focus was placed on multidisciplinary care—bringing together surgeons, oncologists, pathologists, and radiologists to improve patient outcomes.

Global Collaboration & Advocacy

PSOGI continues to lead efforts in expanding access to advanced cancer care globally. This issue underscores inequities in treatment access in low- and middle-income countries and outlines steps toward improving education and infrastructure.

New webinars, training opportunities, and collaborative partnerships were also announced, including initiatives with advocacy groups and research networks dedicated to peritoneal malignancies.

Events & Opportunities

Looking ahead, PSOGI shared upcoming events—including global workshops, congresses, and hybrid meetings featuring translational research and surgical innovation. The issue also opened calls for abstracts and grant submissions supporting early-career investigators.

Voices from the Field

Interviews with leading clinicians and researchers offered fresh insights into the future of abdominal oncology, while brief patient stories highlighted courage and resilience throughout the treatment journey.

The Autumn 2025 PSOGI newsletter features upcoming events, key research publications, and messages from regional coordinators. As always, PSOGI World News offers a global lens on the innovations, challenges, and shared commitment to improving outcomes for patients with peritoneal surface malignancies.

Read the full October 2025 issue of PSOGI World News here:

Read More

If you have questions about your diagnosis and/or treatment options, speak with your doctor to determine the best plan for you.